Lupin, a pharmaceutical company headquartered in India, announced this week it will be expanding in Coral Springs, including building a new laboratory by the end of the year. The expansion will create at least 45 high-skilled positions in Broward County, the company said.
What makes Lupin’s announcement particularly significant is that its new facility will focus on the research and development of new drugs, said Todd Holt, director of business development for the Greater Fort Lauderdale Alliance, with an expertise in the life science industry. Nearly 1,000 biotech, pharmaceutical and medical devices companies call Florida home, according to Enterprise Florida. Broward County has more than 500 life science companies, and recruiting companies with high-paying R&D jobs is a goal of the Alliance.
Xian-Ming Zeng, Lupin’s senior vice president of Inhalation Research and Development, believes the company can recruit high-quality scientists from the South Florida area. “There is a unique opportunity to collaborate with the area’s universities and explore long-term recruitment solutions. Not only does this mean the cost of recruiting is lower but the resulting candidates are highly-trained and desirable as employees,” he said in a statement.
Lupin, a U.S.-owned subsidiary of Lupin Limited of Mumbai, is the fifth largest generics player by prescription. Lupin’s local facility will focus on inhalation products for the treatment of asthma, allergic rhinitis, chronic obstructive pulmonary diseases and other lung diseases, the company said.
Enterprise Florida, the Greater Fort Lauderdale Alliance, Broward County, CareerSource Florida and the Florida Department of Economic Opportunity worked together on the expansion plan.